Historique de carrière de Robert E. Winkler
Anciens postes connus de Robert E. Winkler
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2018 | 19/03/2020 |
| AMICUS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 06/09/2011 | 01/09/2013 |
| ARRAY TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 19/05/2014 | - |
Formation de Robert E. Winkler
| The Hebrew University Hadassah Medical School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Israël | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Bourse
- Insiders
- Robert E. Winkler
- Expérience
